Rapamycin by Ethnicity: Efficacy and Safety

2 source-based articles maintained by the HealthRX.com Editorial Team.

2articles

2topic areas covered

Sep 1, 2024latest review

Rapamycin by Ethnicity: Efficacy and Safety library

Showing 2 of 2 clinical reviews.

SafetySep 1, 2024

Rapamycin (Sirolimus) Hispanic / Latino Safety Profile Differences

A guide to sirolimus pharmacogenomics, dosing, and safety considerations specific to Hispanic and Latino patients, covering CYP3A5 variants, diabetes risk, dyslipidemia, and ethnicity-stratified trial data.

Dosing & MonitoringMay 27, 2026

Rapamycin (Sirolimus) in South Asian Patients: Documented Efficacy Gaps and Dosing Considerations

Evidence-based review of how rapamycin (sirolimus) performs differently in South Asian populations, covering pharmacogenomics, CYP3A5 polymorphisms, metabolic context, and dosing adjustments.